• SENSEX 79,212.53
    -588.90 (--0.74%)
  • BANKNIFTY 54,664.05
    -537.35 (--0.97%)
  • Apollo Hospitals
    6,900.70 5,690.80(%)
  • Waaree Energies
    2,590.20 1,808.65(%)
  • Reliance Industr
    1,288.00 1,115.55(%)
  • SpiceJet
    55.49 79.90(%)
  • Axis Bank
    1,145.75 934.00(%)
  • Dixon Technolog.
    16,092.55 7,772.55(%)
  • Suzlon Energy
    56.78 37.95(%)
  • Vodafone Idea
    7.44 6.60(%)
  • SBI Life Insuran
    1,763.00 1,935.00(%)
  • Tata Motors
    651.45 542.55(%)
  • Bharat Electron
    293.70 221.00(%)
  • Tata Power Co.
    382.00 326.25(%)
  • Reliance Power
    40.91 23.26(%)
  • Eternal Ltd
    226.95 146.85(%)
  • HDFC Bank
    1,891.90 1,430.15(%)
  • Jio Financial
    249.15 198.60(%)
  • Mazagon Dock
    2,585.00 1,046.00(%)
  • Adani Energy Sol
    907.00 588.25(%)
  • Nip. India Nifty
    266.61 242.12(%)
  • Adani Green
    904.00 758.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Morepen Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen
  • BSE Code : 2685.0
  • ISIN : INE083A01026
58.82 -3 (-5.46%)
  • As on 25 Apr 2025 (EOD)

  • Today’s Low

    57.44

  • Today’s High

    62.30

  • Open

    62.22

  • Perv Close

    62.22

  • 52W Low

    42.00

  • 52W High

    100.90

Key Indicators

  • P/E(TTM)

    24.82

  • Mar.Cap (₹Cr.)

    3,223.06

  • Div & Yield %

    0.00

  • Book Value(₹)

    20.95

  • Debt-Equity Ratio

    -5.46

  • AGM Date

    25-Apr-2025

  • EPS

    2.37

  • P/E Ratio

    24.82

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,223.06

  • RONW (%)

    12.08

  • ROCE (%)

    16.12

Score Board

  • Equity (₹ in Cr.)

    109.59

  • BV (₹)

    21.00

  • Sales( ₹ in Cr.)

    1,537.59

  • NP (in Cr.)

    110.94

  • NP Var(%)

    140.0

  • Div%

    0.0

  • CPS (₹)

    2.40

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    3,408.27

  • 52 Week High

    100.90

  • 52 Week Low

    42.00

  • Price BSE

    62.0

  • Price NSE

    62.00

  • Market Capital( in Cr.)

    3,408.27

  • P/C Ratio

    25.60

  • P/E Ratio

    30.60

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,537.59 1,338.88 1,449.27 1,112.42 791.99 717.24
Other Income 12.57 5.76 10.24 11.77 9.42 3.67
Stock Adjustments -5.13 -16.54 -1.74 41.98 7.58 19.46
Total Income 1,545.03 1,328.10 1,457.77 1,166.17 808.99 740.37
EXPENDITURE :            
Raw Materials 945.15 886.48 988.81 778.60 528.67 485.82
Power and Fuel Cost 34.09 23.78 18.93 13.00 12.56 13.18
Employee Cost 160.28 146.19 150.00 123.20 98.07 84.74
Other Manufacturing Expenses 44.19 33.81 23.39 13.57 10.54 9.47
Selling and Administration Expenses 163.47 111.62 87.90 82.36 73.37 67.36
Miscellaneous Expenses 23.47 43.19 49.36 31.30 11.89 11.11
Employee Benefit Expenses 160.28 146.19 150.00 123.20 98.07 84.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,370.64 1,245.08 1,318.39 1,042.03 735.10 671.68
Operating Profit 174.39 83.03 139.37 124.15 73.89 68.69
Interest 3.51 1.98 -7.37 1.79 1.97 2.07
Gross Profit 170.88 81.05 146.74 122.36 71.92 66.62
Depreciation 21.90 18.01 21.19 28.11 34.43 38.01
Profit Before Tax 148.98 63.04 125.55 94.25 37.49 28.61
Current Tax 38.48 16.60 22.00 0.00 5.15 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.44 0.20 2.48 0.00 0.00 0.00
Reported Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 110.94 46.24 101.06 94.25 32.33 28.61
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 217.27 171.03 74.96 -19.29 -51.62 -80.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 5.00 0.00 0.00 0.00
P & L Balance carried down 328.20 217.27 171.03 74.96 -19.29 -51.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.17 0.90 2.12 2.10 0.72 0.64
Earnings Per Share(Adj)-Unit Curr 2.17 0.90 2.12 2.10 0.72 0.64
Book Value 17.39 15.26 11.97 8.92 6.83 6.17
Book Value(Adj)-Unit Curr 17.39 15.26 11.97 8.92 6.83 6.17

Shareholding Pattern

  • Promoter Group

    35.65%

  • Public Share Holding

    64.35%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 154,129,838 28.13 154,129,838 11
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 41,241,750 7.53 41,241,750 24
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 195,371,588 35.65 195,371,588 35
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 60,000 0.01 60,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 3,741,824 0.68 3,741,824 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 10,623,791 1.94 10,623,791 44
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 5,143,530 0.94 5,143,530 4
Mutual Funds / UTI 12,740 0.00 12,740 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 280,000 0.05 280,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 19,861,885 3.62 19,861,885 57
2] Non Institution
Bodies Corporate 13,200,943 2.41 12,567,572 737
Clearing Members 941,858 0.17 941,858 64
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 7,277,355 1.33 7,275,698 3,252
Foreign Non Institution Other 38,530,120 7.03 38,530,120 2
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 30,433,191 5.55 25,615,296 106
Individuals holding nominal share capital up to Rs. 1 lakh 236,725,776 43.20 215,851,578 464,599
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 38,831 0.01 38,831 7
Others 0 0.00 0 0
Sub Total 332,720,226 60.72 306,392,442 468,768
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 547,953,699 100.00 521,625,915 468,860

Company Background

Morepen Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Morepen Laboratories Ltd
  • BSE Code : 2685.0
  • ISIN : INE083A01026

  • Incorporation Year

    1984

  • Registered Office

    Morepen Village
    Nalagarh Road Near Baddi, Solan,
    Himachal Pradesh-173205

  • Telephone

    91-01795-276201-03

  • FAX

    91-01795-276204

  • Chairman

    Sushil Suri

  • Managing Director

    Sushil Suri

  • Company Secretary

    Vipul Kumar Srivatava

  • Auditor

    S P Babuta & Associates

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Morepen Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Morepen Labs. 58.82 1,550.16 1,537.59 24.82 17.08
Abbott India 29,747.90 6,097.18 5,848.91 47.37 44.71
Astrazeneca Phar 8,728.45 1,330.33 1,295.53 225.02 33.26
P & G Health Ltd 5,074.25 1,166.89 1,151.26 35.60 39.76
Glaxosmi. Pharma 2,804.05 3,530.73 3,407.25 55.76 44.44
Cipla 1,525.50 17,645.00 16,574.34 26.15 20.10
Amrutanjan Healt 656.65 437.58 421.23 38.49 20.84
Guj. Themis Bio. 283.70 174.19 169.82 58.74 44.82
Fermenta Biotec. 278.75 315.24 307.09 26.42 4.10
Bliss GVS Pharma 122.05 638.96 605.46 27.93 11.19
Ambalal Sarabhai 37.95 11.70 3.81 16.22 1.92